Eli Lilly and Co at Guggenheim Partners Oncology Day Transcript
Okay. All right. Great. So thanks, everybody, for joining us. Really, really pleased to have Eli Lilly here with us today. Just to my right is Anne White. She's President of Lilly Oncology. And then to Anne's right is Dr. Levi Garraway. He's Head of Oncology, R&D. We also have members of the IR team in the audience here. So thanks to the team for joining us.
Questions & Answers
But I'm going to jump right into questions. And again, I think, maybe -- most importantly, Anne, maybe you can talk to us about the Lilly strategy. Obviously, you guys are working to kind of rebuild and refocus the business. And I don't know, have we closed the Loxo -- actually it was this week?
We're actually planning to close tomorrow.
Tomorrow. Okay. So I thought it was this week. Okay.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |